1-1 of 1
on behalf of JALSG
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lower Dose of Imatinib Provides Outcomes Similar to the Standard Dose Imatinib in Japanese Patients with Early Chronic-Phase CML: The Interim Analyses of JALSG CML202 Study.

Kazunori Ohnishi, Miki Nishimura, Jin Takeuchi, Shin Fujisawa, Tadashi Nagai, Koichi Miyamura, Yukihiko Kimura, Fumiharu Yagasaki, Hideki Akiyama, Noriko Usui, Shigeki Ohtake, on behalf of JALSG
Journal: Blood
Blood (2007) 110 (11): 1044.
https://doi.org/10.1182/blood.V110.11.1044.1044
Published: 2007